DK0935461T3 - Adamantanaminderivater til bekæmpelse af virus fra Borna viridae familien - Google Patents

Adamantanaminderivater til bekæmpelse af virus fra Borna viridae familien

Info

Publication number: DK0935461T3
Authority: DK; Denmark
Prior art keywords: borna; adamantanamine; viruses; derivatives; control
Prior art date: 1996-10-30

Application number

DK97945778T

Other languages

Danish (da)

English (en)

Inventor

Hanns Ludwig

Detlef Dietrich

Liv Bode

Hinderk M Emrich

Original Assignee

Hanns Ludwig

Detlef Dietrich

Hinderk M Emrich

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-30

Filing date

1997-10-23

Publication date

2003-11-24

1997-10-23 Application filed by Hanns Ludwig, Detlef Dietrich, Hinderk M Emrich filed Critical Hanns Ludwig

2003-11-24 Application granted granted Critical

2003-11-24 Publication of DK0935461T3 publication Critical patent/DK0935461T3/da

Links

241000700605 Viruses Species 0.000 title abstract 2
241000776207 Bornaviridae Species 0.000 title 1
DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical class C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 title 1
241000724653 Borna disease virus Species 0.000 abstract 2
230000009385 viral infection Effects 0.000 abstract 2
208000017194 Affective disease Diseases 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
208000019022 Mood disease Diseases 0.000 abstract 1
208000032023 Signs and Symptoms Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000008030 elimination Effects 0.000 abstract 1
238000003379 elimination reaction Methods 0.000 abstract 1
230000002045 lasting effect Effects 0.000 abstract 1
239000000758 substrate Substances 0.000 abstract 1
230000001629 suppression Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK97945778T 1996-10-30 1997-10-23 Adamantanaminderivater til bekæmpelse af virus fra Borna viridae familien DK0935461T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19644998A DE19644998C1 (de)	1996-10-30	1996-10-30	Verwendung von Adamantanaminen oder strukturanaloger Verbindungen zur Bekämpfung von Borna Disease Virus und zur Prophylaxe und Behandlung von Affekterkrankungen und anderen mit BDV-Infektionen verbundenen Störungen bei Mensch und Tier
PCT/DE1997/002455 WO1998018457A1 (fr)	1996-10-30	1997-10-23	Utilisation d'amines d'adamantane ou de composes a structure analogue pour lutter contre le virus de meningo-encephalo-myelite zootique et pour assurer la prophylaxie et le traitement de pathologies affectives et d'autres troubles lies aux infections de la meningo-encephalo-myelite zootique chez l'homme et l'animal

Publications (1)

Publication Number	Publication Date
DK0935461T3 true DK0935461T3 (da)	2003-11-24

Family

ID=7810348

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97945778T DK0935461T3 (da)	1996-10-30	1997-10-23	Adamantanaminderivater til bekæmpelse af virus fra Borna viridae familien

Country Status (16)

Country	Link
US (1)	US6384083B1 (fr)
EP (1)	EP0935461B1 (fr)
JP (1)	JP4290764B2 (fr)
CN (1)	CN1133425C (fr)
AT (1)	ATE245975T1 (fr)
AU (1)	AU722505B2 (fr)
BR (1)	BR9712466A (fr)
CA (1)	CA2306830C (fr)
CZ (1)	CZ148999A3 (fr)
DE (2)	DE19644998C1 (fr)
DK (1)	DK0935461T3 (fr)
ES (1)	ES2207751T3 (fr)
HU (1)	HUP0000386A3 (fr)
IL (1)	IL129612A (fr)
PL (1)	PL189608B1 (fr)
WO (1)	WO1998018457A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10053397A1 (de) *	2000-10-20	2002-05-02	Schering Ag	Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10043321B4 (de) *	2000-08-24	2005-07-28	Neurobiotec Gmbh	Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
US20040122090A1 (en) *	2001-12-07	2004-06-24	Lipton Stuart A.	Methods for treating neuropsychiatric disorders with nmda receptor antagonists
DE10064453A1 (de) *	2000-12-16	2002-07-04	Schering Ag	Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20050124701A1 (en) *	2003-06-11	2005-06-09	Went Gregory T.	Method of targeting a therapeutic agent
UY28650A1 (es) *	2003-12-05	2005-02-28	Forest Laboratories	Memantina para la prevencion o disminucion de la conducta suicida y para el tratamiento de la depresion mayor asociada con esta conducta
US7619007B2 (en) *	2004-11-23	2009-11-17	Adamas Pharmaceuticals, Inc.	Method and composition for administering an NMDA receptor antagonist to a subject
CA2588296A1 (fr)	2004-11-24	2006-06-01	Neuromolecular Pharmaceuticals, Inc.	Composition et methode pour traiter des affections neurologiques
JP5666087B2 (ja)	2005-04-06	2015-02-12	アダマス・ファーマシューティカルズ・インコーポレーテッド	Ｃｎｓ関連疾患の治療のための方法及び組成物
US8393169B2 (en)	2007-09-19	2013-03-12	Emerson Climate Technologies, Inc.	Refrigeration monitoring system and method
AU2010325960C1 (en)	2009-12-02	2015-08-06	Adamas Pharma, Llc	Amantadine compositions and methods of use
CN102241678B (zh)	2011-04-26	2014-10-29	辽宁利锋科技开发有限公司	含有脂环结构化合物的抗肿瘤作用与应用
US8835507B2 (en) *	2012-02-21	2014-09-16	Vymed Corporation	Adamantane derivatives possessing anti-viral and anti-microbial activity
US10154971B2 (en)	2013-06-17	2018-12-18	Adamas Pharma, Llc	Methods of administering amantadine
DE102018009721A1 (de) *	2017-12-29	2019-07-04	Euroimmun Medizinische Labordiagnostika Ag	Verfahren zur Diagnose einer Bornavirus-Infektion

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR6482M (fr) *	1916-09-20	1968-11-25
DE2224539A1 (de) *	1972-05-19	1973-12-06	Merz & Co	Aminoadamantanverbindungen und verfahren zu ihrer herstellung
US4174407A (en) *	1978-01-13	1979-11-13	Sumitomo Chemical Company, Limited	Antiviral agent
US4148896A (en) *	1978-02-22	1979-04-10	E. I. Du Pont De Nemours And Company	Antidepressant combination
US4174047A (en) *	1978-03-06	1979-11-13	3-in-1, Inc.	Vending machine for newspapers and the like
DE3921062A1 (de) *	1989-06-23	1991-01-03	Lange Werner	Therapie und prophylaxe von infektionen mit retroviren mit 1-adamantanamin hydrochlorid (amantadin) allein oder in kombination mit anderen antiviralen substanzen
DE4014672A1 (de) *	1990-05-08	1991-11-14	Werner E G Prof Dr Mueller	Verwendung von adamantan-derivaten zur zytoprotektion von nicht-infizierten und virus-infizierten lymphozyten als auch anderen zelltypen
WO1992017168A1 (fr) *	1991-04-04	1992-10-15	The Children's Medical Center Corporation	Procede permettant d'empecher les lesions neuronales dues aux recepteurs de n-methyl-d-aspartate
US5576355A (en) *	1993-06-04	1996-11-19	Mobil Oil Corp.	Diamondoid derivatives for pharmaceutical use
DE19510189A1 (de) *	1995-03-21	1996-09-26	Hartmut Dr Goebel	Verwendung von Amantadin

1996
- 1996-10-30 DE DE19644998A patent/DE19644998C1/de not_active Expired - Fee Related
1997
- 1997-10-23 DK DK97945778T patent/DK0935461T3/da active
- 1997-10-23 PL PL97333059A patent/PL189608B1/pl not_active IP Right Cessation
- 1997-10-23 CA CA002306830A patent/CA2306830C/fr not_active Expired - Fee Related
- 1997-10-23 JP JP51988498A patent/JP4290764B2/ja not_active Expired - Lifetime
- 1997-10-23 EP EP97945778A patent/EP0935461B1/fr not_active Expired - Lifetime
- 1997-10-23 DE DE59710517T patent/DE59710517D1/de not_active Expired - Lifetime
- 1997-10-23 CN CNB971993416A patent/CN1133425C/zh not_active Expired - Lifetime
- 1997-10-23 HU HU0000386A patent/HUP0000386A3/hu unknown
- 1997-10-23 US US09/297,489 patent/US6384083B1/en not_active Expired - Lifetime
- 1997-10-23 AT AT97945778T patent/ATE245975T1/de not_active IP Right Cessation
- 1997-10-23 BR BR9712466-4A patent/BR9712466A/pt not_active IP Right Cessation
- 1997-10-23 AU AU51162/98A patent/AU722505B2/en not_active Ceased
- 1997-10-23 CZ CZ991489A patent/CZ148999A3/cs unknown
- 1997-10-23 IL IL12961297A patent/IL129612A/xx not_active IP Right Cessation
- 1997-10-23 ES ES97945778T patent/ES2207751T3/es not_active Expired - Lifetime
- 1997-10-23 WO PCT/DE1997/002455 patent/WO1998018457A1/fr not_active Ceased

Also Published As

Publication number	Publication date
AU5116298A (en)	1998-05-22
IL129612A0 (en)	2000-02-29
HUP0000386A1 (hu)	2000-12-28
WO1998018457A1 (fr)	1998-05-07
US6384083B1 (en)	2002-05-07
BR9712466A (pt)	1999-12-21
CA2306830A1 (fr)	1998-05-07
EP0935461A1 (fr)	1999-08-18
IL129612A (en)	2003-02-12
ES2207751T3 (es)	2004-06-01
CN1235540A (zh)	1999-11-17
CZ148999A3 (cs)	1999-11-17
PL189608B1 (pl)	2005-08-31
AU722505B2 (en)	2000-08-03
JP4290764B2 (ja)	2009-07-08
DE59710517D1 (de)	2003-09-04
JP2001502701A (ja)	2001-02-27
ATE245975T1 (de)	2003-08-15
PL333059A1 (en)	1999-11-08
HUP0000386A3 (en)	2001-04-28
CA2306830C (fr)	2008-07-08
EP0935461B1 (fr)	2003-07-30
DE19644998C1 (de)	1998-06-10
CN1133425C (zh)	2004-01-07

Similar Documents

Publication	Publication Date	Title
DE59710517D1 (de)	2003-09-04	Adamantanaminenderivate zur bekämpfung von viren der familie bornaviridae
DK1465626T3 (da)	2008-11-17	Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf
ID27787A (id)	2001-04-26	Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan
CR20120007A (es)	2012-02-24	2-indolinonas sustituidas con pirrolos inhibidores de proteinquinasas (divisional exp. 6728)
BR9710372A (pt)	1999-08-17	Composto composi-Æo farmac-utica e processos para o tratamento de uma doen-a inflamatÄria e de doen-as mediadas pela cliclooxigenase
NO20072352L (no)	2007-05-31	Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet
AP2000001942A0 (en)	2000-12-31	Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
BR9502707A (pt)	1996-06-04	Composto composição farmacêutica e método para o tratamento de uma afecção
ATE334668T1 (de)	2006-08-15	Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
NO20021830D0 (no)	2002-04-18	Sammensetninger egnet til å forhindre og behandle forkjölelse og influensaliknende symptomer samt fremgangsmåter vedfremstilling derav
DE69432984D1 (de)	2003-09-04	Therapeutische substituierte guanidine
DE69435303D1 (de)	2010-09-02	Er behandlung von krankheiten bei denen eine cytok
BR9604973A (pt)	1998-06-09	Uma composição farmacêutica contendo carbamatos de n-cloro fenila e tiocarbamatos de n-cloro fenila para inibição de crescimento de vírus e cânceres
NO20054744L (no)	2005-10-14	Behandling av Alzheimers sykdom
CL2004000710A1 (es)	2005-05-27	Composicion antimicrobiana y antiparasitaria formada por un antibiotico derivado del cloranfenicol o tianfenicol, un endectocida y por lo menos un vehiculo aceptable, y su uso para tratar enfermedades respiratorias y parasitarias de los bovinos.
DE69032613D1 (de)	1998-10-08	Zusammensetzung und verfahren zur behandlung viraler infektionen
ATE290857T1 (de)	2005-04-15	Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DK0610336T3 (da)	2002-07-22	Behandling af neurologiske tilstande ved hjælp af en interleukin-1-hæmmende forbindelse
BG93298A (bg)	1993-12-24	Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
EA200400535A1 (ru)	2005-06-30	ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ
ATE293994T1 (de)	2005-05-15	Multivalente rekombinante antikörper zur behandlung von hrv infektionen
RU93056841A (ru)	1996-11-10	Способы лечения и защиты позвоночных от паразитов, композиции на основе дисульфонилметанов для борьбы с паразитами, новые соединения
KR960000248A (ko)	1996-01-25	골대사 질환 치료제
ATE282609T1 (de)	2004-12-15	Neue substituierte n-methyl-n-(4-(4-(1h- benzimidazol-2-yl) (1,4)diazepan-1-yl)-2- (aryl)butyl)benzamide zur behandlung von allergischen krankheiten
ES2166912T3 (es)	2002-05-01	Composiciones, que comprenden bismuto y uno o mas agentes antimicrobianos, para el tratamiento y prevencion de trastornos gastrointestinales.